Stock PRQR PROQR THERAPEUTICS N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions ProQR Therapeutics N.V.

Equities

PRQR

NL0010872495

Delayed Nasdaq
Other stock markets
 09:30:00 2024-04-29 am EDT 		5-day change 1st Jan Change
1.97 USD +1.55% Intraday chart for ProQR Therapeutics N.V. -1.50% -0.51%
Mar. 14 Chardan Raises ProQR Therapeutics' PT to $2.50 From $2, Says ADAR-Based Therapeutics to Enter Clinical Development, Keeps Buy Rating MT
Mar. 13 ProQR Therapeutics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

  1. Stock Market
  2. Equities
  3. PRQR Stock
  4. Revisions ProQR Therapeutics N.V.